Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System
University of Rochester Medical Center · Washington University in St. Louis
Abstract
Amyloid beta-peptide (Abeta) clearance from the central nervous system (CNS) maintains its low levels in brain. In Alzheimer's disease, Abeta accumulates in brain possibly because of its faulty CNS clearance and a deficient efflux across the blood-brain barrier (BBB). By using human-specific enzyme-linked immunosorbent assays, we measured a rapid 30 mins efflux at the BBB and transport via the interstitial fluid (ISF) bulk flow of human-unlabeled Abeta and of Abeta transport proteins, apolipoprotein E (apoE) and apoJ in mice. We show (i) Abeta40 is cleared rapidly across the BBB via low-density lipoprotein receptor-related protein (LRP)1 at a rate of 0.21 pmol/min g ISF or 6-fold faster than via the ISF flow;…
Citation impact
- FWCI
- 11.14
- Percentile
- 100%
- References
- 43
Authors
7Topics & keywords
- Central nervous system
- Amyloid (mycology)
- Peptide
- Neuroscience
- P3 peptide
- Amyloid precursor protein
- Alzheimer's disease
- Chemistry
- No poverty